These promising results—from an NIH-funded study that exclusively evaluated Masimo SET ® in a vulnerable, clinically fragile ...

Apple has been embroiled in a six-year legal battle over one of its Apple Watch health apps. The end may finally be in sight, and here's what Apple has to say about it. Anna Gragert Senior Editor, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The USITC has denied a request by Masimo to reinstate a ban on the Apple Watch, closing its case on alleged blood oxygen patent infringement. The long-running lawsuit over the Apple Watch has ...

“The Federal Circuit [said] that the ITC permissibly treated the Masimo Watch as the domestic industry article and reasonably viewed the prototype units as physical articles practicing the asserted ...

Apple's current blood oxygen sensing implementation in the U.S. does not infringe on patents owned by Masimo and Apple will not face a revived import ban, a U.S. International Trade Commission judge ...

Irvine-based Masimo is being acquired by Danaher Corp. in a deal with an enterprise value of about $9.9 billion, allowing it to gain a foothold in the medical supply business. Danaher will pay $180 ...

Danaher will acquire pulse oximeter maker Masimo in a $9.9 billion deal, as the life science firm looks to bulk up its diagnostics portfolio. The companies said on Tuesday that Danaher will pay $180 ...

Feb 17 (Reuters) - Danaher, ⁠a $150 ⁠billion U.S. company that makes ⁠tools used in developing and testing medicines, on Tuesday agreed to buy Masimo for $9.9 billion, expanding in patient-monitoring ...